Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity.
Ribas A, Albanell J, Bellmunt J, Solé-Calvo LA, Bermejo B, Gallardo E, Vidal R, Vera R, Eres N, Carulla J, Baselga J. Ribas A, et al. Among authors: albanell j. J Clin Oncol. 1996 May;14(5):1573-80. doi: 10.1200/JCO.1996.14.5.1573. J Clin Oncol. 1996. PMID: 8622074 Clinical Trial.
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer.
Bellmunt J, Guillem V, Paz-Ares L, González-Larriba JL, Carles J, Albanell J, Tabernero JM, Cortés-Funes H, Baselga J. Bellmunt J, et al. Among authors: albanell j. Eur J Cancer. 2000 Jul;36 Suppl 2:17-25. doi: 10.1016/s0959-8049(00)00081-2. Eur J Cancer. 2000. PMID: 10908844 Review.
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.
Bellmunt J, Guillem V, Paz-Ares L, González-Larriba JL, Carles J, Batiste-Alentorn E, Sáenz A, López-Brea M, Font A, Nogué M, Bastús R, Climent MA, de la Cruz JJ, Albanell J, Banús JM, Gallardo E, Diaz-Rubio E, Cortés-Funes H, Baselga J. Bellmunt J, et al. Among authors: albanell j. J Clin Oncol. 2000 Sep 15;18(18):3247-55. doi: 10.1200/JCO.2000.18.18.3247. J Clin Oncol. 2000. PMID: 10986057 Clinical Trial.
New drugs and new approaches in metastatic bladder cancer.
Bellmunt J, de Wit R, Albiol S, Tabernero J, Albanell J, Baselga J. Bellmunt J, et al. Among authors: albanell j. Crit Rev Oncol Hematol. 2003 Aug;47(2):195-206. doi: 10.1016/s1040-8428(03)00082-9. Crit Rev Oncol Hematol. 2003. PMID: 12900012 Review.
261 results